GleamWall
中文EN

SRRK Scholar Rock Holding Corp

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1727196 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-17.0%
TTM EPS YoY-2.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-71,732.3%
Net margin-72,563.2%
FCF margin-54,370.7%
EBITDA margin-71,501.6%

Returns

ROE-200.0%
ROA-96.4%
ROIC (approx.)-1,144.3%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets62.2%
Debt / equity1.16x
Current ratio5.41x
Interest coverage-29.23x

Cash quality & payout

Operating cash flow / net income0.75x
Accruals ratio-24.2%
Payout ratio—
Capex / revenue35.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$0—
R&D expense$208.44M$184.55M
SG&A expense$176.21M$67.50M
Operating income-$384.64M-$252.05M
Interest expense$6.89M$6.84M
Pretax income-$377.73M-$246.29M
Net income-$377.94M-$246.29M
EBITDA-$382.99M-$250.12M
EPS (basic)-3.29-2.47
EPS (diluted)-3.29-2.47
Weighted avg. shares (diluted)114.70M99.84M
Balance sheet
Cash & equivalents$323.53M$180.28M
Short-term investments$44.04M$259.40M
Receivables$0—
Inventory$0—
Current assets$385.15M$451.17M
PP&E, net$1.71M$2.76M
Total assets$404.27M$474.92M
Current liabilities$55.42M$46.94M
Long-term debt$99.71M$50.15M
Total debt$99.71M$50.15M
Total liabilities$158.78M$106.29M
Shareholders' equity$245.49M$368.63M
Net debt-$223.82M-$130.14M
Shares outstanding108.46M93.82M
Cash flow statement
Operating cash flow-$300.04M-$200.95M
Capital expenditure$602,000$98,000
Free cash flow-$300.64M-$201.05M
Investing cash flow$218.69M-$76.06M
Financing cash flow$228.40M$353.03M
Depreciation & amortization$1.66M$1.94M
Stock-based compensation$75.60M$36.63M

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.